Catalyst Wire Dossier Catalyst Wire Dossier

RAB001 (LLP2A-Ale)

LLP2A-Ale · ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RAB001 (LLP2A-Ale), covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: RAB001(LLP2A-Ale) in Healthy Subjects [Phase 1]

See pricing